169 related articles for article (PubMed ID: 2885739)
1. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
Convents A; De Backer JP; Convents D; Vauquelin G
Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
[TBL] [Abstract][Full Text] [Related]
2. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
4. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
[TBL] [Abstract][Full Text] [Related]
5. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
Valet P; Senard JM; Devedjian JC; Planat V; Salomon R; Voisin T; Drean G; Couvineau A; Daviaud D; Denis C
J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045
[TBL] [Abstract][Full Text] [Related]
6. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
7. Differences between agonist and antagonist binding to alpha 1-adrenergic receptors of intact and broken-cell preparations.
Sladeczek F; Bockaert J; Mauger JP
Mol Pharmacol; 1983 Nov; 24(3):392-7. PubMed ID: 6138703
[TBL] [Abstract][Full Text] [Related]
8. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding.
Convents A; De Backer JP; Vauquelin G
Biochem Pharmacol; 1987 Aug; 36(15):2497-503. PubMed ID: 3038126
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455
[TBL] [Abstract][Full Text] [Related]
11. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
12. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
Nasseri A; Minneman KP
Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
[TBL] [Abstract][Full Text] [Related]
13. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
14. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
15. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
16. Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.
Severne Y; Ijzerman A; Nerme V; Timmerman H; Vauquelin G
Mol Pharmacol; 1987 Jan; 31(1):69-73. PubMed ID: 2880285
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.
Morrow AL; Creese I
Mol Pharmacol; 1986 Apr; 29(4):321-30. PubMed ID: 3010073
[TBL] [Abstract][Full Text] [Related]
18. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
Baron BM; Siegel BW
Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227
[TBL] [Abstract][Full Text] [Related]
19. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
Galitzky J; Lafontan M; Paris H; Berlan M
J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
[TBL] [Abstract][Full Text] [Related]
20. Nonadrenergic imidazoline binding sites on human platelets.
Piletz JE; Sletten K
J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]